NCT03756298 2026-04-23Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast CancerNational Cancer Center, KoreaPhase 2 Active not recruiting284 enrolled